Pluri (PLUR) EBIT (QoQ) (2010 - 2025)
Pluri (PLUR) EBIT (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.94 Bn | 132.09 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.59 Bn | 78.60 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.67 Bn | 60.49 Bn | 1.37 Bn |
| 4 | Moderna | 57.81 Bn | 52.67 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.41 Bn | 10.02 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - |
| 10 | Pluri | 15.74 Mn | 3.26 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.46% |
| Sep 30, 2025 | 4.09% |
| Jun 30, 2025 | -22.61% |
| Mar 31, 2025 | -8.94% |
| Dec 31, 2024 | 4.64% |
| Sep 30, 2024 | 13.85% |
| Jun 30, 2024 | -9.04% |
| Mar 31, 2024 | -6.16% |
| Dec 31, 2023 | 3.05% |
| Sep 30, 2023 | 17.83% |
| Jun 30, 2023 | 7.83% |
| Mar 31, 2023 | -6.30% |
| Dec 31, 2022 | 3.52% |
| Sep 30, 2022 | 22.06% |
| Jun 30, 2022 | 15.21% |
| Mar 31, 2022 | 2.96% |
| Dec 31, 2021 | 5.65% |
| Sep 30, 2021 | 21.57% |
| Jun 30, 2021 | -2.54% |
| Mar 31, 2021 | -8.80% |